Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BGBB-3227 by BeiGene for Gastrointestinal Tract Cancer: Likelihood of Approval
BGBB-3227 is under clinical development by BeiGene and currently in Phase I for Gastrointestinal Tract Cancer. According to GlobalData, Phase...